title: Time course changes of anti- and pro-apoptotic proteins in apigenin-induced genotoxicity.
abstract: BACKGROUND
  Apigenin (4',5,7-trihydroxyflavone, AP), an active component of many medicinal Chinese herbs, exhibits anticancer properties in vitro and in vivo. This study aims to investigate the genotoxic, cytostatic, and cytotoxic effects of AP and time course changes in the levels of anti- and pro-apoptotic proteins involved in the DNA damage response in HepG2 cells.
  
  
  METHODS
  The genotoxic potential of AP was determined by sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) analysis. The levels of cytostaticity and cytotoxicity were evaluated by the proliferation rate and mitotic indices, respectively. MTT was used to study cytotoxicity, while the induction of apoptosis and the expression of apoptosis-related proteins were determined by ELISA.
  
  
  RESULTS
  At concentrations greater than 10 μM, AP decreased cell survival in a dose- (48 h: 10 vs. 20 μΜ, P < 0.001 and 20 vs. 50 μΜ, P = 0.005; 72 h: 10 vs. 20 μΜ, P < 0.001 and 20 vs. 50 μΜ, P = 0.001) and time-dependent manner (20 μΜ: 24 vs. 48 h, P < 0.001 and 48 vs. 72 h, P = 0.003; 50 μΜ: 24 vs. 48 h, P < 0.001 and 48 vs. 72 h, P < 0.001; 100 μΜ: 24 vs. 48 h, P < 0.001 and 48 vs. 72 h, P < 0.001). SCEs rates, cell proliferation, and mitotic divisions were also affected in a dose-dependent manner (P < 0.001). There was no change in the frequency of aberrant cells (1 μΜ ΑP: P = 0.554; 10 μM AP: P = 0.337; 20 μΜ AP: P = 0.239). Bcl-2 levels were reduced 3 h after AP administration (P = 0.003) and remained reduced throughout the 48 h observation period (6 h, P = 0.044; 12 h, P = 0.001; 24 h, P = 0.042; 48 h, P = 0.012). Bax and soluble Fas exhibited a transient upregulation 24 h after AP treatment. The Bax/Bcl-2 ratio was also increased at 12 h and remained increased throughout the 48 h observation period.
  
  
  CONCLUSIONS
  AP exhibited dose-dependent genotoxic potential in HepG2 cells. The protein levels of sFas, Bcl-2, and Bax were affected by AP to promote cell survival and cell death, respectively.
authors: Cell Cultures Unit, Laboratory of Experimental Surgery and Surgical Research, Faculty of Medicine, Democritus University of Thrace, Dragana, Alexandroupolis, Greece. atsarouc@med.duth.gr.
authors: Fotini
authors: F
authors: Papachristou
authors: Ekaterini
authors: E
authors: Chatzaki
authors: Athanasios
authors: A
authors: Petrou
authors: Ioanna
authors: I
authors: Kougioumtzi
authors: Nikolaos
authors: N
authors: Katsikogiannis
authors: Alexandros
authors: A
authors: Papalambros
authors: Grigorios
authors: G
authors: Tripsianis
authors: Constantinos
authors: C
authors: Simopoulos
authors: Alexandra K
authors: AK
authors: Tsaroucha
references: Int J Cancer. 1982 Jul 15;30(1):27-33
references: 6288577
references: Biomed Environ Sci. 2005 Feb;18(1):65-70
references: 15861781
references: Nucleic Acids Res. 2010 May;38(9):3005-18
references: 20110258
references: Mol Cell Biol. 2004 Feb;24(3):1341-50
references: 14729977
references: Int J Oncol. 2007 Jan;30(1):233-45
references: 17143534
references: J Exp Med. 1995 Sep 1;182(3):821-8
references: 7650488
references: Science. 1994 Mar 25;263(5154):1759-62
references: 7510905
references: DNA Repair (Amst). 2008 Oct 1;7(10):1705-16
references: 18644472
references: Mol Carcinog. 2012 Dec;51(12):952-62
references: 22006862
references: J Cell Biol. 1999 Apr 5;145(1):99-108
references: 10189371
references: Mol Cell. 2005 Aug 19;19(4):475-84
references: 16109372
references: Evid Based Complement Alternat Med. 2012;2012:873175
references: 22844340
references: Mutat Res. 2003 Nov 27;532(1-2):103-15
references: 14643432
references: Free Radic Biol Med. 2002 Mar 1;32(5):386-93
references: 11864778
references: Mutat Res. 1979 May;60(3):329-37
references: 113672
references: Chin Med. 2011 Jun 09;6:22
references: 21651825
references: Anticancer Res. 1997 Jan-Feb;17(1A):85-91
references: 9066634
references: Chem Biol Interact. 2011 Sep 5;193(2):180-9
references: 21756884
references: Nature. 1977 Jul 21;268(5617):235-6
references: 887153
references: J Agric Food Chem. 2010 Oct 13;58(19):10661-7
references: 20853834
references: Mutat Res. 2012 Aug 30;747(1):71-76
references: 22516036
references: Nat Cell Biol. 2007 Jun;9(6):683-90
references: 17486112
references: Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11
references: 1933891
references: Eur J Cancer. 1999 Oct;35(10):1517-25
references: 10673981
references: Free Radic Biol Med. 2008 May 15;44(10):1833-45
references: 18342637
references: Carcinogenesis. 2000 Apr;21(4):633-9
references: 10753197
references: J Ethnopharmacol. 2005 Aug 22;100(1-2):72-9
references: 16009521
references: Proc Natl Acad Sci U S A. 1974 Aug;71(8):3162-6
references: 4137928
references: Int J Oncol. 2010 Jun;36(6):1477-84
references: 20428772
references: Toxicol In Vitro. 2008 Apr;22(3):625-31
references: 18206345
references: Food Chem Toxicol. 2009 Oct;47(10):2445-9
references: 19577607
references: Cancer Res. 1990 Feb 1;50(3):499-502
references: 2105157
references: Cell Death Differ. 2007 Jan;14(1):3-9
references: 17068503
references: Carcinogenesis. 1998 Feb;19(2):369-72
references: 9498291
references: Arch Pharm Res. 2007 Oct;30(10):1328-35
references: 18038912
references: Cancer Res. 1998 Sep 15;58(18):4117-21
references: 9751622
references: Biochemistry. 1985 Nov 5;24(23):6406-10
references: 3002439
references: Gene. 2008 Aug 15;420(1):34-41
references: 18571879
references: Mutat Res. 1979 Jul;61(2):297-307
references: 90339
references: Chem Biol Interact. 2004 Jun 30;148(1-2):37-48
references: 15223355
references: Mutat Res. 1992 Nov 16;270(2):87-95
references: 1383740
references: Semin Cancer Biol. 1998;8(5):345-57
references: 10101800
references: Mutat Res. 2005 Aug 1;585(1-2):96-104
references: 15886050
references: Fitoterapia. 2012 Dec;83(8):1616-22
references: 22999990
references: Anal Bioanal Chem. 2002 Sep;374(2):294-9
references: 12324852
references: Clin Cancer Res. 2009 Sep 1;15(17):5435-44
references: 19690196
references: Cancer Lett. 2006 Jun 18;237(2):207-14
references: 16023288
references: Chin Med. 2010 May 13;5:17
references: 20465823
references: Environ Mol Mutagen. 2002;40(4):266-76
references: 12489117
references: Cell. 1994 Oct 21;79(2):329-39
references: 7954799
references: Mutat Res. 2000 Aug;463(2):111-72
references: 10913908
references: Cancer Res. 1985 May;45(5):2025-30
references: 4039220
references: Future Oncol. 2011 Feb;7(2):263-83
references: 21345145
references: Carcinogenesis. 1999 Oct;20(10):1945-52
references: 10506109
references: Toxicology. 2006 Jan 16;217(2-3):206-12
references: 16289292
references: Nature. 1974 Sep 13;251(5471):156-8
references: 4138930
references: Pharm Res. 2010 Jun;27(6):962-78
references: 20306120
references: Arch Biochem Biophys. 2007 Oct 15;466(2):274-82
references: 17870050
references: Mutat Res. 1975 Nov;30(2):273-8
references: 1207711
references: J Nutr. 2003 Nov;133(11 Suppl 1):3800S-3804S
references: 14608117
references: Food Chem Toxicol. 2008 May;46(5):1555-69
references: 18234413
references: Toxicol In Vitro. 2006 Oct;20(7):1168-72
references: 16759833
references: Hepatology. 2000 Nov;32(5):1060-8
references: 11050057
references: Nat Med. 1996 May;2(5):574-7
references: 8616718
references: DNA Cell Biol. 2008 Aug;27(8):433-42
references: 18491957
references: Mutat Res. 1983 May;120(2-3):193-9
references: 6843582
references: Front Biosci. 1996 Jan 01;1:d12-8
references: 9159204
references: Hepatology. 1999 Apr;29(4):1208-14
references: 10094966
references: J Pharm Pharmacol. 2006 Dec;58(12):1655-60
references: 17331330
references: Mol Carcinog. 2000 Jun;28(2):102-10
references: 10900467
references: Biochim Biophys Acta. 1981 Jun 26;654(1):129-34
references: 7272306
references: Mol Carcinog. 2004 Feb;39(2):114-26
references: 14750216
references: J Clin Invest. 1997 Feb 1;99(3):403-13
references: 9022073
references: Crit Rev Toxicol. 1988;19(1):43-86
references: 3056658
references: Cancer Res. 2000 Oct 15;60(20):5815-24
references: 11059778
references: J Immunol. 1995 Mar 15;154(6):2706-13
references: 7533181
references: Mutagenesis. 2008 Sep;23(5):347-54
references: 18502769
references: Fitoterapia. 2010 Sep;81(6):590-4
references: 20176089
references: Mutat Res. 1991 Feb;246(2):301-22
references: 1996126
references: Acta Biochim Pol. 2010;57(1):95-7
references: 20300661
references: Lab Invest. 1993 Oct;69(4):415-29
references: 7693996
references: Anticancer Drugs. 2009 Sep;20(8):746-51
references: 19584706
references: PLoS One. 2011;6(12):e29169
references: 22216199
references: EMBO J. 2000 Jul 3;19(13):3398-407
references: 10880452
references: Mutat Res. 2001 Sep 4;486(4):217-47
references: 11516927
references: Mol Carcinog. 2005 Sep;44(1):11-20
references: 15924350
references: Life Sci. 2005 Feb 4;76(12):1367-79
references: 15670616
references: Hum Genet. 1981;58(3):235-54
references: 6459983
references: Toxicol Appl Pharmacol. 2005 Jun 15;205(3):213-24
references: 15922007
references: Oncogene. 1994 Jun;9(6):1767-73
references: 8183575
references: Cancer Res. 1986 Apr;46(4 Pt 1):1599-602
references: 3948148